0
Options Newsletter 02-1997
$0.00
In stock
Product Details
- Editorial: Kessler Leaves FDA In A Cloud of Controversy
- Hydrazine Sulfate: Russian Rocket Fuel or Effective Cancer Therapy?
- FDA Stops Dr. Springer From Treating His Famous Patients
- Burzynski On Trial
- Dr. Coulter Presents Govallo Paper in London and Berlin
- The Stockholm Protocol
- BioPro Trial for Prostate Cancer
- Senator Grassley Vows Support for Medical Treatments Act
Options Newsletter 02-1997
Display prices in:
USD